Clinical Trial Update: Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial for patients with chronic hepatitis C genotype 1 or 3 who relapse after prior pegylated interferon/ribavirin therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: University of Hamburg-Eppendorf | Conditions: Hepatitis C, Chronic, Relapse | Phase 3 | Status: UNKNOWN